Belvedere Trading’s Immunogen Inc IMGN Stock Holding History

Belvedere Trading’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,662	Closed	-$375K	–	1092
2023 Q4	$375K	Sell	12,662 -4,335	-26%	-$86.3K	﹤0.01%	205
2023 Q3	$270K	Sell	16,997 -2,861	-14%	-$47.6K	﹤0.01%	181
2023 Q2	$375K	Buy	19,858 +9,824	+98%	+$116K	﹤0.01%	187
2023 Q1	$38.5K	Buy	+10,034	New	+$42.8K	﹤0.01%	627

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Belvedere Trading's IMGN Position: Q1 2024 in Review

Belvedere Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,662 shares — an estimated $375K sold.

Belvedere Trading first reported a position in IMGN in Q1 2023 and held it in 4 quarters. The position peaked at $375K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Belvedere Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Belvedere Trading sold 12,662 Immunogen Inc shares in Q1 2024, an estimated $375K.
Belvedere Trading first reported a position in Immunogen Inc in Q1 2023 and held it in 4 quarters.
Belvedere Trading's Immunogen Inc position peaked at $375K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.